Nutritional supplements that contain curcumin -- a natural anti-inflammatory compound -- may protect the eyes from the ...
Dr. Shiri Shulman from Assuta discusses the importance of continuity in treatment during wartime and innovative therapies ...
The therapy, called photobiomodulation or “red light” therapy, can reduce the risk of vision loss and slow progression of the ...
MedPage Today on MSN3d
Approval of Bevacizumab Biosimilar Could Eliminate Access to Low-Cost AMD TherapyCHICAGO -- Availability of a bevacizumab biosimilar for ophthalmic use could eliminate a lower-cost treatment option for a ...
Patients with neovascular age-related macular degeneration diagnosed by a primary care clinician may be more likely to miss ...
According to Research by SNS Insider, Dry AMD Market Growth is Driven by New Therapies, Geriatric Population Boom, and Advancements in R&D.Pune, Oct. 17, 2024 (GLOBE NEWSWIRE) -- SNS Insider reports ...
In data presented at the 128th annual meeting of the American Academy of Ophthalmology in Chicago, the two-year study finds ...
called the results a “milestone” in treating severe vision loss caused by age-related macular degeneration. “Prior to this, there have been no real treatment options to improve vision for ...
The following is a summary of “Submacular hemorrhage rates following anti-vascular endothelial growth factor injections for ...
Pharmaceuticals announced that the first patient has been dosed in the Phase 3 LUGANO clinical trial of DURAVYU, formerly ...
Analyst Yi Chen of H.C. Wainwright reiterated a Buy rating on EyePoint Pharmaceuticals (EYPT – Research Report), retaining the price ...
Roche has released positive topline one-year findings from a Phase IV trial of Vabysmo (faricimab) to treat diabetic macular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback